Oral bioavailability of pentachlorophenol from soils of varying characteristics using a rat model

Relative bioavailability of soil-bound polycyclic aromatic hydrocarbons in goats

This study aimed at determining the relative bioavailability (RB) of three soil-bound PAH model compounds (phenanthrene [PHE], pyrene [PYR] and benzo[a]pyrene [BaP]) in four lactating goats. RB was estimated by comparing the urinary or milk excretion of the major mono-hydroxylated metabolites of PAHs after ingestion of PAH spiked-soil and -oil feeds. A series of three increasing doses were orally administered in order to estimate the dose response of the two different matrices. The results of this study reveal that urinary excretion prevailed compared to milk excretion (30-fold higher). The recovery rate of mono-hydroxylated metabolites of PAHs in urine and milk indicate that PYR was absorbed at a minimum level of 36%. 3-OH PHE excreted in urine suggests a minimal absorption of at least 5% for PHE. 3-OH BaP remained under the limits of detection and quantification and no RB could be calculated for this compound. RB of soil-bound PYR compared to PYR in oil was 61% and 50% in milk and urine, respectively. Thus, a significantly reduced RB of PYR in soil has been shown. On the other hand, no significant differences were observed between oil and soil for urinary 3-OH PHE (RB=100%). These results show that the soil matrix significantly reduces the bioavailability of certain PAHs. The decrease of bioavailability seems to be dependent on the compounds, i.e. higher for PYR than for PHE. This study also suggests that soil ingestion should be taken into account in risk assessment studies.

Bioavailability of 2,3′,4,4′,5-pentachlorobiphenyl (PCB118) and 2,2′,5,5′-tetrachlorobiphenyl (PCB52) from soils using a rat model and a physiologically based extraction test

The bioavailability of coplanar 2,3',4,4',5-pentachlorobiphenyl (PCB118) and nonplanar 2,2',5,5'-tetrachlorobiphenyl (PCB52) from soils representing a range in organic carbon (OC), clay content and pH were investigated using an in vivo rat model and an in vitro physiologically based extraction test (PBET) to assess the role of soil and chemical properties on bioavailabilty. Affinity to soil and persistence of PCBs have been shown to increase with increasing soil organic carbon (OC) content, PCB chlorination, and PCB coplanarity. In the in vivo tests for both PCB118 and PCB52, the AUCs following iv injection were significantly higher than the AUCs for all soil groups, indicating that the soil matrix can reduce the absolute bioavailability of PCB118 and PCB52. However, no significant differences were detected between soils of different properties. In the in vitro PBET, significant differences in the mobilization of PCB118 and PCB52 were observed among soils, and PCBs had the least mobilization from the soil with the highest OC content consistent with hydrophobic partitioning theory. Also, significantly less PCB118 was mobilized relative to PCB52 in the PBET assay, showing the potential impact of spatial orientation and chlorine content on bioavailability. No correlation between the in vitro PBET and the in vivo rat model was observed for the PCBs. Although the in vitro PBET and related assays may serve as an indicator of bioavailability, it is likely to underestimate what can be released from a soil in an in vivo assay.